CID 3487139

Lissoclinamide 3

Structural Information

Molecular Formula
C33H41N7O5S2
SMILES
CCC(C)C1C2=NC(CS2)C(=O)NC(C3=NC(=CS3)C(=O)NC(C(=O)N4CCCC4C5=NC(C(O5)C)C(=O)N1)CC6=CC=CC=C6)C
InChI
InChI=1S/C33H41N7O5S2/c1-5-17(2)25-32-37-22(16-47-32)27(41)34-18(3)31-36-23(15-46-31)28(42)35-21(14-20-10-7-6-8-11-20)33(44)40-13-9-12-24(40)30-39-26(19(4)45-30)29(43)38-25/h6-8,10-11,15,17-19,21-22,24-26H,5,9,12-14,16H2,1-4H3,(H,34,41)(H,35,42)(H,38,43)
InChIKey
MXZCBFXSFNFJTR-UHFFFAOYSA-N
Compound name
8-benzyl-22-butan-2-yl-15,26-dimethyl-27-oxa-13,20-dithia-6,9,16,23,28,29,30-heptazapentacyclo[23.2.1.111,14.118,21.02,6]triaconta-1(28),11,14(30),21(29)-tetraene-7,10,17,24-tetrone
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

9
Patents

679.26105 Da
Monoisotopic Mass

3.6
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 680.26833 236.1
[M+Na]+ 702.25027 241.1
[M-H]- 678.25377 234.7
[M+NH4]+ 697.29487 235.9
[M+K]+ 718.22421 240.0
[M+H-H2O]+ 662.25831 241.3
[M+HCOO]- 724.25925 225.8
[M+CH3COO]- 738.27490 237.2
[M+Na-2H]- 700.23572 223.3
[M]+ 679.26050 236.9
[M]- 679.26160 236.9
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe